Cardioprotective role of peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone in a unique murine model of diabetic cardiopathy

Giri Suresh R.; Bhoi Bibhuti; Jain Mukul R.; Gatne Madhumanjiri M.

首页> 外文期刊>Life sciences >Cardioprotective role of peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone in a unique murine model of diabetic cardiopathy

【24h】

Cardioprotective role of peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone in a unique murine model of diabetic cardiopathy

机译：过氧化物酶体增殖物激活的受体-γ激动剂罗格列酮在糖尿病性心脏病的唯一鼠模型中的心脏保护作用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: Rosiglitazone (RSZ), a PPAR gamma agonist was potent efficacious insulin sensitizing blockbuster drug for treatment of Type 2 diabetes mellitus (T2DM) but the benefit of PPAR gamma activation in congestive heart failure (CHF) was controversial. The present work was planned to study the role of RSZ in diabetic cardiopathy.

机译：目的：PPARγ激动剂罗格列酮（RSZ）是治疗2型糖尿病（T2DM）的有效的胰岛素敏感重磅炸弹药物，但PPARγ激活在充血性心力衰竭（CHF）中的益处尚有争议。目前的工作计划是研究RSZ在糖尿病性心脏病中的作用。

著录项

来源
《Life sciences》 |2016年第null期|共13页
作者
Giri Suresh R.; Bhoi Bibhuti; Jain Mukul R.; Gatne Madhumanjiri M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Amiloride; Diabetic cardiopathy; PPAR gamma agonist; Rosiglitazone; Type 2 diabetes mellitus;

机译：阿米洛利;糖尿病性心脏病;PPARγ激动剂;罗格列酮;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Cardioprotective role of peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone in a unique murine model of diabetic cardiopathy [J] . Giri Suresh R., Bhoi Bibhuti, Jain Mukul R., Life sciences . 2016,第Null期

机译：过氧化物体增殖物激活受体-γ-γ激动剂，Rosiglitazone在糖尿病心术的独特鼠模型中的心脏保护作用
2. Agonist of peroxisome proliferator-activated receptor-gamma, rosiglitazone, reduces renal injury and dysfunction in a murine sepsis model. [J] . Lee S, Kim W, Kang KP, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2005,第6期

机译：过氧化物酶体增殖物激活受体γ的激动剂罗格列酮可减轻小鼠败血症模型的肾脏损伤和功能障碍。
3. The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients. [J] . Sidhu JS, Cowan D, Kaski JC Journal of the American College of Cardiology . 2003,第10期

机译：罗格列酮（一种过氧化物酶体增殖物激活的受体-γ激动剂）对非糖尿病性冠状动脉疾病患者内皮细胞激活，C反应蛋白和纤维蛋白原水平的影响。
4. Molecular Docking Studies of Flavonoids of Noni Fruit (Morinda citrifolia L.) to Peroxisome Proliferator-Activated Receptor-Gamma (PPAR_γ) [C] . Fikry Awaluddin, Andrianopsyah Mas Jaya Putra, Supandi International Conference on Computation for Science and Technology . 2015

机译：非果（Morinda Citrifolia L.）黄酮类化合物对过氧化物增殖物激活受体 - γ（PPAR_γ）的分子对接研究
5. Peroxisome Proliferator-activated Receptor-γ (PPARγ) Agonists: Potential Novel Treatment for HIV-1 Associated Brain Inflammation [D] . Omeragic, Amila . 2020

机译：过氧化物体增殖物激活受体-γ（PPARγ）激动剂：对HIV-1相关脑炎症的潜在新待遇
6. Peroxisome proliferator-activated receptor agonist rosiglitazone improves host defense against Pseudomonas aeruginosa in a murine model of pneumonia [O] . Crisitina Lyra Nagae, Cassiano Felippe Gonçalves-de-Albuquerque, Alessandra Silveira Ferreira, 2013

机译：过氧化物酶体增殖物激活的受体激动剂罗格列酮改善了肺炎鼠模型中铜绿假单胞菌的宿主防御能力
7. The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients [O] . Sidhu Jagdip S, Cowan Dahlia, Kaski Juan-Carlos 2003

机译：罗格列酮（一种过氧化物酶体增殖物激活的受体-γ激动剂）对非糖尿病性冠状动脉疾病患者内皮细胞激活，C反应蛋白和纤维蛋白原水平标志物的影响

Cardioprotective role of peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone in a unique murine model of diabetic cardiopathy

摘要

著录项

相似文献

相关主题

期刊订阅